HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutations in BIN1 associated with centronuclear myopathy disrupt membrane remodeling by affecting protein density and oligomerization.

Abstract
The regulation of membrane shapes is central to many cellular phenomena. Bin/Amphiphysin/Rvs (BAR) domain-containing proteins are key players for membrane remodeling during endocytosis, cell migration, and endosomal sorting. BIN1, which contains an N-BAR domain, is assumed to be essential for biogenesis of plasma membrane invaginations (T-tubules) in muscle tissues. Three mutations, K35N, D151N and R154Q, have been discovered so far in the BAR domain of BIN1 in patients with centronuclear myopathy (CNM), where impaired organization of T-tubules has been reported. However, molecular mechanisms behind this malfunction have remained elusive. None of the BIN1 disease mutants displayed a significantly compromised curvature sensing ability. However, two mutants showed impaired membrane tubulation both in vivo and in vitro, and displayed characteristically different behaviors. R154Q generated smaller membrane curvature compared to WT N-BAR. Quantification of protein density on membranes revealed a lower membrane-bound density for R154Q compared to WT and the other mutants, which appeared to be the primary reason for the observation of impaired deformation capacity. The D151N mutant was unable to tubulate liposomes under certain experimental conditions. At medium protein concentrations we found 'budding' structures on liposomes that we hypothesized to be intermediates during the tubulation process except for the D151N mutant. Chemical crosslinking assays suggested that the D151N mutation impaired protein oligomerization upon membrane binding. Although we found an insignificant difference between WT and K35N N-BAR in in vitro assays, depolymerizing actin in live cells allowed tubulation of plasma membranes through the K35N mutant. Our results provide insights into the membrane-involved pathophysiological mechanisms leading to human disease.
AuthorsTingting Wu, Zheng Shi, Tobias Baumgart
JournalPloS one (PLoS One) Vol. 9 Issue 4 Pg. e93060 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24755653 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Actins
  • Adaptor Proteins, Signal Transducing
  • BIN1 protein, human
  • Cross-Linking Reagents
  • Liposomes
  • Mutant Proteins
  • Nuclear Proteins
  • Recombinant Proteins
  • Tumor Suppressor Proteins
Topics
  • Actins (metabolism)
  • Adaptor Proteins, Signal Transducing (chemistry, genetics)
  • Animals
  • Cell Membrane (pathology)
  • Cross-Linking Reagents (metabolism)
  • Humans
  • Liposomes (metabolism)
  • Mice
  • Microscopy, Fluorescence
  • Mutant Proteins (chemistry, metabolism)
  • Myopathies, Structural, Congenital (genetics)
  • Nuclear Proteins (chemistry, genetics)
  • Point Mutation (genetics)
  • Polymerization
  • Protein Multimerization
  • Protein Structure, Tertiary
  • Recombinant Proteins (chemistry, metabolism)
  • Tumor Suppressor Proteins (chemistry, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: